ResearcherBaylor College of MedicineActive in the last 2 years
Eric Jay Silberfein
Matched on ORCID iD 0000-0002-4024-5227; OpenAlex author ID A5046734879. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 8
- The Role of Routine Staging Laparoscopy for Pancreatic Adenocarcinoma in Underserved Populations: A 14-Year Experience at a Safety-Net Hospital. Last author DOI 10.1002/jso.70299↗
- Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences for Survival. Co-author DOI 10.1002/jso.70408↗
- Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2022.02.058↗
- Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Co-author DOI 10.1016/j.surg.2018.08.003↗
- Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Co-author DOI 10.1016/j.surg.2017.05.003↗
- Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Co-author DOI 10.3390/nu9030243↗
- Pancreatic cancer disparities in African Americans. Co-author DOI 10.1097/mpa.0000000000000323↗
- A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival. Co-author DOI 10.1245/s10434-012-2361-z↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George Van Buren · 6 shared papers, 2015–2026 · strength 0.78
- Paper Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences f… DOI 10.1002/jso.70408↗
- Paper Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. DOI 10.1016/j.amjsurg.2022.02.058↗
- Paper Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. DOI 10.1016/j.surg.2018.08.003↗
- Ernest Ramsay Camp · 2 shared papers, 2022–2026 · strength 0.50
- David M. Holmes · 1 shared paper, 2026 · strength 0.43
- William E. Fisher · 4 shared papers, 2015–2022 · strength 0.39
- Paper Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. DOI 10.1016/j.amjsurg.2022.02.058↗
- Paper Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. DOI 10.1016/j.surg.2018.08.003↗
- Paper Value of lymph node positivity in treatment planning for early stage pancreatic cancer. DOI 10.1016/j.surg.2017.05.003↗
- Derek J. Erstad · 1 shared paper, 2026 · strength 0.33
- John C. Johnson · 1 shared paper, 2026 · strength 0.33
- William E Fisher · 1 shared paper, 2026 · strength 0.33
- Nader Nabile Massarweh · 3 shared papers, 2017–2019 · strength 0.22
- Paper Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. DOI 10.1016/j.surg.2018.08.003↗
- Paper Value of lymph node positivity in treatment planning for early stage pancreatic cancer. DOI 10.1016/j.surg.2017.05.003↗
- Paper Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. DOI 10.3390/nu9030243↗
- Hop S. Tran Cao · 3 shared papers, 2017–2019 · strength 0.22
- Paper Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. DOI 10.1016/j.surg.2018.08.003↗
- Paper Value of lymph node positivity in treatment planning for early stage pancreatic cancer. DOI 10.1016/j.surg.2017.05.003↗
- Paper Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. DOI 10.3390/nu9030243↗
- Onur Cagri Kutlu · 1 shared paper, 2022 · strength 0.16
- Townes A Mickel · 1 shared paper, 2022 · strength 0.16
- Omar Barakat · 2 shared papers, 2017–2019 · strength 0.16
- Katherine A. Baugh · 1 shared paper, 2019 · strength 0.10
- Matthew H. G. Katz · 1 shared paper, 2017 · strength 0.07
- Taylor M. Gilliland · 1 shared paper, 2017 · strength 0.06
- Somala Mohammed · 1 shared paper, 2015 · strength 0.06
- Shumaila N. Khawja · 1 shared paper, 2015 · strength 0.06
- Benjamin Musher · 1 shared paper, 2015 · strength 0.06
- Tien C. Ko · 1 shared paper, 2012 · strength 0.04
- Lillian S. Kao · 1 shared paper, 2012 · strength 0.04
- Curtis Jackson Wray · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.